<?xml version="1.0" encoding="UTF-8" standalone="yes"?><drugRecordsOutput><serviceExecutionTime>366</serviceExecutionTime><Drug id="106706"><DrugName>sodium phenylbutyrate (oral/tablet, urea cycle disorder), Shiner Pharm</DrugName><DrugNamesKey><Name id="43105268">Phenbuty</Name><Name id="42748497">sodium phenylbutyrate</Name></DrugNamesKey><DrugSynonyms><Name><Value>sodium phenylbutyrate</Value><Types><Type>USAN</Type><Type>BANN</Type></Types></Name><Name><Value>sodium phenylbutyrate (oral/tablet, urea cycle disorder), Shiner Pharm</Value></Name><Name><Value>Phenbuty</Value><Types><Type>Trade Name</Type></Types></Name><Name><Value>1716-12-7</Value><Types><Type>CAS RN</Type></Types></Name></DrugSynonyms><CompanyOriginator id="1079426">Shiner Pharm Corp</CompanyOriginator><CompaniesPrimary><Company id="1079426">Shiner Pharm Corp</Company></CompaniesPrimary><CrossReferences><SourceEntity id="338" type="ciIndication"><TargetEntity id="D014511" type="MeSH"/><TargetEntity id="-1869018783" type="omicsDisease"/><TargetEntity id="3868" type="siCondition"/></SourceEntity><SourceEntity id="2574" type="Action"><TargetEntity id="1213" type="Mechanism">Histone Deacetylase (HDAC) Inhibitors</TargetEntity></SourceEntity></CrossReferences><PhaseHighest id="L">Launched</PhaseHighest><PhaseHighestDetailed><FirstLaunched>Uremia - Taiwan - Dec-2015</FirstLaunched></PhaseHighestDetailed><RegulatoryDesignations><RegulatoryDesignation id="1">Orphan Drug</RegulatoryDesignation></RegulatoryDesignations><IndicationsPrimary><Indication id="338">Uremia</Indication></IndicationsPrimary><ActionsPrimary><Action id="2574">Histone deacetylase inhibitor</Action></ActionsPrimary><ActionsSecondary><Action id="1467">Renal system agent</Action><Action id="1757">Nitrogen metabolism modulator</Action></ActionsSecondary><Technologies><Technology id="585">Oral formulation</Technology><Technology id="595">Tablet formulation</Technology><Technology id="762">Small molecule therapeutic</Technology></Technologies><LastModificationDate>2018-01-02T17:45:29.000Z</LastModificationDate><ChangeDateLast>2018-01-03T00:00:00.000Z</ChangeDateLast><AddedDate>2017-07-13T00:00:00.000Z</AddedDate><DevelopmentProfile><Summary><displayLabel>Summary</displayLabel><value>&lt;Summary&gt;&lt;para&gt;&lt;ulink linkID="1079426" linkType="Company"&gt;Shiner Pharm&lt;/ulink&gt; has developed and launched Phenbuty, an oral capsule formulation of &lt;ulink linkID="10039" linkType="Drug"&gt;sodium phenylbutyrate&lt;/ulink&gt;, for the treatment of congenital urea cycle disorders involving deficiencies of carbamylphosphate synthetase (CPS), ornithine transcarbamylase (OTC), or argininosuccinic acid synthetase (AS) [&lt;ulink linkID="1943652" linkType="Reference"&gt;1943652&lt;/ulink&gt;]. In December 2015, the drug was approved in Taiwan [&lt;ulink linkID="1943650" linkType="Reference"&gt;1943650&lt;/ulink&gt;]. The product was assumed to be launched shortly after [&lt;ulink linkID="1943652" linkType="Reference"&gt;1943652&lt;/ulink&gt;].&lt;/para&gt;&lt;/Summary&gt;</value></Summary><Regulatory><displayLabel>Regulatory</displayLabel><value>&lt;Regulatory&gt;&lt;para&gt;In January 2008, the product was granted orphan drug designation in Taiwan [&lt;ulink linkID="1941145" linkType="Reference"&gt;1941145&lt;/ulink&gt;], [&lt;ulink linkID="1941147" linkType="Reference"&gt;1941147&lt;/ulink&gt;].  In December 2015, the drug was approved in Taiwan [&lt;ulink linkID="1943650" linkType="Reference"&gt;1943650&lt;/ulink&gt;]. The product was assumed to be launched shortly after [&lt;ulink linkID="1943652" linkType="Reference"&gt;1943652&lt;/ulink&gt;].&lt;/para&gt;&lt;/Regulatory&gt;</value></Regulatory></DevelopmentProfile><IDdbDevelopmentStatus><DevelopmentStatusCurrent><Company id="1079426">Shiner Pharm Corp</Company><Country id="TW">Taiwan</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="338">Uremia</Indication><StatusDate>2015-12-31T00:00:00.000Z</StatusDate><Source id="1943652" type="CORPORATE"/></DevelopmentStatusCurrent><DevelopmentStatusHistoric><Company id="1079426">Shiner Pharm Corp</Company><Country id="TW">Taiwan</Country><DevelopmentStatus id="DR" sortOrder="7">Discovery</DevelopmentStatus><Indication id="338">Uremia</Indication><StatusDate>2008-01-22T00:00:00.000Z</StatusDate></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="1079426">Shiner Pharm Corp</Company><Country id="TW">Taiwan</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="338">Uremia</Indication><StatusDate>2015-12-07T00:00:00.000Z</StatusDate><Source id="1943650" type="OTHER"/></DevelopmentStatusHistoric></IDdbDevelopmentStatus><RegulatoryDesignationStatus><Row><RegulatoryDesignation id="1">Orphan Drug</RegulatoryDesignation><OwnerCompany id="1079426">Shiner Pharm Corp</OwnerCompany><Country id="TW">Taiwan</Country><Indication id="338">Uremia</Indication><AwardedIndication>Treatment of congenital urea cycle disorders involving deficiencies of carbamylphosphate synthetase (CPS), ornithine transcarbamylase (OTC), or argininosuccinic acid synthetase (AS)</AwardedIndication><DesignationType id="1">Treatment</DesignationType><DesignationApplicationStatus id="1">Granted</DesignationApplicationStatus><MileStoneDate>2008-01-22T00:00:00.000Z</MileStoneDate></Row></RegulatoryDesignationStatus><Targets><Target id="PTGT-00922"><Name>Histone deacetylase</Name><SwissprotNumbers><Swissprot>O22446</Swissprot><Swissprot>P56521</Swissprot></SwissprotNumbers></Target></Targets><ReasonsForUpdate><ReasonForUpdate><Reason>Development Status Updated</Reason><Description>One or more development status entries have been updated</Description></ReasonForUpdate><ReasonForUpdate><Reason>Reference Added</Reason><Description>2 references added [&lt;ulink url="utility.reference?i_reference_id=1943652" linkType="reference" linkID="1943652"&gt;1943652&lt;/ulink&gt;, &lt;ulink url="utility.reference?i_reference_id=1943650" linkType="reference" linkID="1943650"&gt;1943650&lt;/ulink&gt;]							</Description></ReasonForUpdate><ReasonForUpdate><Reason>Indexing Updated</Reason><Description>Indexing updated</Description></ReasonForUpdate></ReasonsForUpdate><StructureSmiles><Smiles>c1ccc(cc1)CCCC(=O)[O-].[Na+]</Smiles></StructureSmiles><hasSWOTs>N</hasSWOTs></Drug></drugRecordsOutput>